Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: An open-label pilot randomized controlled trial

BMC Pregnancy and Childbirth

Volumn 11, Issue , 2011, Pages

  Roberts, Christine L ^a,b   Rickard, Kristen ^b   Kotsiou, George ^b   Morris, Jonathan M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANESTAN; CLOTRIMAZOLE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT;

ADULT; ARTICLE; CANDIDA; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VAGINA CANDIDIASIS; ADOLESCENT; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; ISOLATION AND PURIFICATION; PILOT STUDY; PREGNANCY COMPLICATION; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; AUSTRALIA; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CLOTRIMAZOLE; FEMALE; HUMANS; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 79952479528     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-11-18     Document Type: Article

References (21)

1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371(9606):75-84. 10.1016/S0140-6736(08)60074-4, 18177778.
2. The Cochrane Library Cochrane Database of Systematic Reviews. John Wiley & Sons, (accessed April 2010), The Cochrane Library., http://www.thecochranelibrary.com/view/0/AboutTheCochraneLibrary.html
3. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 2004, 329(7462):371. 10.1136/bmj.38169.519653.EB, 509340, 15294856.
4. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1998, 178(2):374-380. 10.1016/S0002-9378(98)80028-8, 9500502.
5. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorsgard K, McFee J. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995, 173(1):157-167. 10.1016/0002-9378(95)90184-1, 7631673.
6. Czeizel AE, Rockenbauer M. A lower rate of preterm birth after clotrimazole therapy during pregnancy. Paediatr Perinat Epidemiol 1999, 13(1):58-64. 10.1046/j.1365-3016.1999.00157.x, 9987785.
7. Czeizel AE, Fladung B, Vargha P. Preterm birth reduction after clotrimazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004, 116(2):157-163. 10.1016/j.ejogrb.2004.02.011, 15358456.
8. Banhidy F, Acs N, Puho EH, Czeizel AE. Rate of preterm births in pregnant women with common lower genital tract infection: a population-based study based on the clinical practice. J Matern Fetal Neonatal Med 2009, 22(5):410-418. 10.1080/14767050902801645, 19529998.
9. Morrison EA, Cushman LF. Prevention of preterm delivery. N Engl J Med 2007, 357(19):1979-1980. 10.1056/NEJMc072557, 17992732.
10. Sobel JD. Vulvovaginal candidosis. Lancet 2007, 369(9577):1961-1971. 10.1016/S0140-6736(07)60917-9, 17560449.
11. Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev 2001, (4):CD000225.
12. Tabrizi SN, Pirotta MV, Rudland E, Garland SM. Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics. Mycoses 2006, 49(6):523-524. 10.1111/j.1439-0507.2006.01312.x, 17022774.
13. Hansson L, Hedner T, Dahlof B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press 1992, 1(2):113-119. 10.3109/08037059209077502, 1366259.
14. Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J. Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J Hypertens 2003, 21(7):1291-1298. 10.1097/00004872-200307000-00016, 12817175.
15. Chaim W, Mazor M, Wiznitzer A. The prevalence and clinical significance of intraamniotic infection with Candida species in women with preterm labor. Arch Gynecol Obstet 1992, 251(1):9-15. 10.1007/BF02718273, 1550392.
16. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med 2005, 18(4):241-247. 10.1080/13506120500223241, 16318974.
17. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511.
18. Polk BF. Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery. The John Hopkins Study of Cervicitis and Adverse Pregnancy Outcome. Am J Epidemiol 1989, 129(6):1247-1257.
19. Czeizel AE, Toth M, Rockenbauer M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology 1999, 10(4):437-440. 10.1097/00001648-199907000-00016, 10401880.
20. Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol 1987, 69(5):751-755.
21. Roberts CL, Morris JM, Rickard KR, Giles WB, Simpson JM, Kotsiou G, Bowen JR. Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]. BMC Pregnancy and Childbirth 2011, 11:19.